Gamage TF et al. |
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569. |
2014 |
Behav Pharmacol |
pmid:24603340
|
Kwilasz AJ et al. |
Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats. |
2014 |
Behav Pharmacol |
pmid:24583930
|
Qin M et al. |
Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome. |
2015 |
Behav. Brain Res. |
pmid:25979787
|
Pedroza-Llinás R et al. |
CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning. |
2013 |
Behav. Brain Res. |
pmid:23018128
|
Umathe SN et al. |
Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. |
2011 |
Behav. Brain Res. |
pmid:21549765
|
Thiemann G et al. |
The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. |
2008 |
Behav. Brain Res. |
pmid:17988751
|
Limebeer CL et al. |
Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex interferes with anticipatory nausea in a rat model. |
2016 |
Behav. Neurosci. |
pmid:26974857
|
De Petrocellis L and Di Marzo V |
An introduction to the endocannabinoid system: from the early to the latest concepts. |
2009 |
Best Pract. Res. Clin. Endocrinol. Metab. |
pmid:19285257
|
Borrelli F and Izzo AA |
Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. |
2009 |
Best Pract. Res. Clin. Endocrinol. Metab. |
pmid:19285259
|
Bermúdez-Silva FJ et al. |
The role of the pancreatic endocannabinoid system in glucose metabolism. |
2009 |
Best Pract. Res. Clin. Endocrinol. Metab. |
pmid:19285263
|
Jones BR et al. |
Surrogate matrix and surrogate analyte approaches for definitive quantitation of endogenous biomolecules. |
2012 |
Bioanalysis |
pmid:23088461
|
Catanzaro G et al. |
Anandamide increases swelling and reduces calcium sensitivity of mitochondria. |
2009 |
Biochem. Biophys. Res. Commun. |
pmid:19679102
|
Soltys J et al. |
Regulation of neural progenitor cell fate by anandamide. |
2010 |
Biochem. Biophys. Res. Commun. |
pmid:20691161
|
Sugiura T et al. |
Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities. |
1996 |
Biochem. Biophys. Res. Commun. |
pmid:8573114
|
Chen J et al. |
Finding of endocannabinoids in human eye tissues: implications for glaucoma. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15823551
|
Maccarrone M et al. |
Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:11095952
|
De Petrocellis L et al. |
Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9070224
|
Deutsch DG et al. |
Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9070252
|
Di Marzo V et al. |
Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11181068
|
Randall MD et al. |
An endogenous cannabinoid as an endothelium-derived vasorelaxant. |
1996 |
Biochem. Biophys. Res. Commun. |
pmid:8954092
|